Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
LUCID DIAGNOSTICS INC.
About LUCD
Lucid Diagnostics Inc. is a commercial-stage medical diagnostics technology company. The Company is focused on patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux or simply reflux, that leads to esophageal precancer and cancer, specifically highly lethal esophageal adenocarcinoma (EAC). The Company’s products include EsoGuard and EsoCheck. EsoGuard is a bisulfite-converted next generation sequencing (NGS) DNA assay performed on surface esophageal cells collected with EsoCheck. EsoCheck is a noninvasive swallowable balloon capsule catheter device capable of sampling surface esophageal cells in office procedures. It consists of a vitamin pill-sized rigid plastic capsule tethered to a thin silicone catheter from which a soft silicone balloon with textured ridges emerges to swab surface esophageal cells. It is also developing EsoCure, is an Esophageal Ablation Device, which is a technology that allows a clinician to treat dysplastic BE.
Find out what a historical investment in LUCID DIAGNOSTICS INC. would be worth today using our LUCD stock calculator.
Market Capitalisation
$182.78M
Price-earnings ratio
-
Dividend yield
0.00%
Volume
1.09M
High today
$1.02
Low today
$0.97
Open price
$0.97
52-week high
$1.63
52-week low
$0.90
Ready to start your investing journey with Stake?
Open an accountHow do I buy LUCD shares in Australia?
Buying LUCD shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in LUCID DIAGNOSTICS INC. in minutes.
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in LUCD
What is the ticker symbol of LUCID DIAGNOSTICS INC.?
The ticker symbol for LUCID DIAGNOSTICS INC. is LUCD.
How much is one share of LUCD?
One share of LUCD is valued at $1.01 as of 10 June 2026.
What is the market capitalisation of LUCID DIAGNOSTICS INC. LUCD?
As of 10 June 2026 LUCID DIAGNOSTICS INC. has a market cap of $182.78M.
What is the 52-week high for LUCID DIAGNOSTICS INC. stock?
The LUCID DIAGNOSTICS INC. 52-week high stock price is $1.63.
What is the 52-week low for LUCID DIAGNOSTICS INC. stock?
The LUCID DIAGNOSTICS INC. 52-week low stock price is $0.90.
Can I buy LUCD shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy LUCD shares and over 12,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in LUCD on Stake
- Buy LUCD from US$3 brokerage
- Invest in 9,500+ U.S. stocks and ETFs
- Own a slice of LUCD from only US$10 with fractional shares
Stock shown for demonstrative purposes only. US$3 brokerage up to US$30,000.
LUCD related stocks